These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3097469)

  • 21. [Molsidomine in the treatment of coronary insufficiency].
    Weber S
    Rev Med Interne; 1987; 8(4):437-43. PubMed ID: 2892240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of strophanthin on cardiovascular function and on tolerance of exercise in patients with angina pectoris treated with beta-adrenergic blocking].
    Volta G; Pavarani A; Barbaresi F; Starcich R
    G Clin Med; 1967 Oct; 48(10):1043-53. PubMed ID: 5605712
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dose-dependent acute effect and long-term modification by molsidomine of portal and cardiac hemodynamics in patients with liver cirrhosis].
    Hüppe D; Jäger D; Tromm A; Barmeyer J; May B
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():65-8, 76. PubMed ID: 7968910
    [No Abstract]   [Full Text] [Related]  

  • 24. [Inhibition of thrombocyte function in coronary heart disease. Results with molsidomine (Corvaton)].
    Z Kardiol; 1991; 80 Suppl 5():1-70. PubMed ID: 1776328
    [No Abstract]   [Full Text] [Related]  

  • 25. [Predicting the effectiveness of nitrosorbide with regard to increasing tolerance to physical loads].
    Sledzevskaia IK; Il'iash MG
    Ter Arkh; 1986; 58(5):85-7. PubMed ID: 3526616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molsidomine in the treatment of ischemic heart disease].
    Sterkowicz S
    Wiad Lek; 1987 Oct; 40(20):1389-95. PubMed ID: 3328427
    [No Abstract]   [Full Text] [Related]  

  • 27. [Efficacy of corvaton in the long-term ambulatory treatment of heart failure in patients with rheumatic heart lesions].
    Koshlia VI
    Ter Arkh; 1986; 58(11):51-5. PubMed ID: 3824191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemodynamics and coronary dynamics under ISDN long-term therapy].
    Wortmann A; Bachmann K; Deuber HJ; Roth E
    Z Kardiol; 1986; 75 Suppl 3():68-76. PubMed ID: 3798997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of diltiazem on rest and stress hemodynamics in coronary disease].
    Biamino G; Oeff M; Schröder R
    Z Kardiol; 1984 Aug; 73(8):504-9. PubMed ID: 6495810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preload or afterload reduction: which is more beneficial for patients with ischemic heart disease?
    Caralis DG; Kyriakides Z
    Cardiovasc Drugs Ther; 1988 May; 2(1):79-82. PubMed ID: 3154698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hemodynamic and coronary effects of molsidomine in patients with stable coronary insufficiency in the basal state, during an atrial stimulation test and a cold test].
    Gourgon R; Neukirch F; Zygelman M; Michel PL; Mérillon JP; Pansard Y; Squara P; Laurent S; Dahan M; Juliard JM
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):529-34. PubMed ID: 6689395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biorhythm influence on the course of ischemic heart disease during combined treatment with molsidomine and anaprilin].
    Vakaliuk IP
    Ter Arkh; 1986; 58(12):49-50. PubMed ID: 3824212
    [No Abstract]   [Full Text] [Related]  

  • 33. Nitrate tolerance: a clinically significant problem?
    Rudolph W; Blasini R
    Herz; 1984 Jun; 9(3):115-22. PubMed ID: 6430765
    [No Abstract]   [Full Text] [Related]  

  • 34. [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].
    Hug J; Hasenfuss G; Wollschläger H; Just HJ; Bonzel T
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():34-7. PubMed ID: 7968899
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary heart disease. Hemodynamic response to exercise before and after nitroglycerin.
    Di Giorgi S; West RO; Parker JO
    Mal Cardiovasc; 1968; 9(1):29-50. PubMed ID: 4981691
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of intravenous administration of nitroglycerin and SIN-1 or molsidomine on epicardial arterial diameter in patients with stable coronary heart disease].
    Münzel T; Kurz S; Heitzer T; Luhmann C; Just H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():38-41. PubMed ID: 7968900
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in intracardiac hemodynamics and the tolerance for physical loading as affected by Nitrong in persons suffering from ischemic heart disease].
    Gasilin VS; Shevchenko OP; Maksumov EIu; Lupanov VP
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):59-64. PubMed ID: 6789850
    [No Abstract]   [Full Text] [Related]  

  • 39. [Indications for the use of molsidomine in patients with chronic cor pulmonale].
    Gavrisiuk VK; Iachnik AI; Diachenko AP; Krasnostup NA; Morskaia ND
    Klin Med (Mosk); 1988 Jun; 66(6):56-9. PubMed ID: 3184805
    [No Abstract]   [Full Text] [Related]  

  • 40. [Peripheral hemodynamics and metabolic parameters influenced by amrinone at rest and following handgrip stress].
    Peters P; Saborowski F; Griebenow R
    Z Kardiol; 1986 Dec; 75(12):751-6. PubMed ID: 3825225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.